-

Shareholder Alert: Robbins LLP Announces Shareholder Class Action Against Immunomedics, Inc. (IMMU) Survives Motion to Dismiss

SAN DIEGO & MORRIS PLAINS, N.J.--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP reminds investors that purchasers of Immunomedics, Inc. (NASDAQ: IMMU) filed a class action complaint against the company for alleged violations of the Securities Exchange Act of 1934 between April 20, 2016 and June 2, 2016. Immunomedics, a clinical-stage biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer. The company is developing its antibody-drug conjugate IMMU-12.

If you suffered a loss as a result of Immunomedics' misconduct, click here.

Shareholder Class Action Alleging Immunomedics, Inc. (IMMU) Made Materially False and Misleading Statements Survives Motion to Dismiss

According to the complaint, on April 19, 2016, Immunomedics announced that the Company would present updated results for IMMU-132 treatment at The American Society of Clinical Oncology ("ASCO"). However, on June 2, 2016, media outlets reported that ASCO had removed Immunomedics regarding the Company's IMMU-132 breast cancer drug from ASCO's annual meeting. ASCO explained their decision, revealing that Immunomedics misrepresented that the Company's abstract for IMMU-132 contained updated and previously undisclosed results from a mid-stage study, when in fact that data was actually old and previously seen. On this news, Immunomedics' stock fell almost 15% to close at $4.52 per share on June 3, 2016. Finally, on June 1, 2020, U.S. District Judge Katharine S. Hayden denied Immunomedics' motion to dismiss, stating that the plaintiff had sufficiently alleged the Company had made false or misleading statements about its ASCO presentation. Her decision paves the way for litigation to proceed.

Immunomedics, Inc. (IMMU) Shareholders Have Legal Options

Contact us to learn more:
Leo Kandinov
(800) 350-6003
lkandinov@robbinsllp.com
Shareholder Information Form

Want to be notified if a class action against Immunodenics settles? Want to receive free alerts about companies engaged in wrongdoing? Sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Leo Kandinov
Robbins LLP
LKandinov@robbinsllp.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsllp.com

Industry:

Robbins LLP

NASDAQ:IMMU
Release Versions
English
$Cashtags
$IMMU
Hashtags
#ClassAction
#Finance
#Investment
#Investor
#Lawsuit
#Securities
#Shareholder
#Shareholderrights
#StockAlert
#StockMarketData
#StockMarketNews
#StockNews
#StockTrading
#Stocks
#Trader
#shareholderrightslawfirm

Contacts

Leo Kandinov
Robbins LLP
LKandinov@robbinsllp.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Investor Notice: Robbins LLP Informs Investors of the PicS N.V. Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired PicS N.V. (NASDAQ: PICS) securities pursuant and/or traceable to the Registration Statement and Prospectus issued in connection with the Company's January 30, 2026 initial public offering ("IPO"). PicS operates one of the largest digital banks in Brazil. The Company offers various payment, credit, insurance, and investment products across both...

Investor Notice: Robbins LLP Informs Investors of the Grail, Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Grail, Inc. (NASDAQ: GRAL) securities between May 13, 2025, and February 19, 2026. Grail, Inc. describes itself as a commercial stage healthcare company with a focus on early cancer detection through screening methodology.For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.The Allegations: R...

Commvault Systems, Inc. Class Action Reminder - Robbins LLP Encourages CVLT Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Commvault Systems, Inc. (NASDAQ: CVLT) securities between April 29, 2025 and January 26, 2026. Commvault is a data protection company. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. What is the class period? April 29, 2025 – January 26, 2026 What are the allegations? Robbins LLP is In...
Back to Newsroom